Treatment of depression in patients with heart disease

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 20, 1999, Pages 34-37

  Roose, Steven P ^a   Spatz, Erica ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG SAFETY; HEART DEATH; HEART DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; ISCHEMIC HEART DISEASE; ORTHOSTATIC HYPOTENSION; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; SYMPATHETIC TONE; THROMBOCYTE ACTIVATION;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BUPROPION; COMORBIDITY; DEATH, SUDDEN; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; HEART BLOCK; HEART DISEASES; HUMANS; HYPOTENSION, ORTHOSTATIC; MYOCARDIAL ISCHEMIA; NORTRIPTYLINE; PAROXETINE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; VENTRICULAR FIBRILLATION;

EID: 0032836348     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Malzberg B. Mortality among patients with involutional melancholia. Am J Psychiatry 1937;93:1231-1238
2. Black DW, Warrack G, Winokur G. The Iowa record-linkage study, III: excess mortality among patients with "functional" disorders. Arch Gen Psychiatry 1985;42:82-88
3. Weeke A. Causes of death in manic depressives. In: Schou M, Stromgren E, eds. Origin, Prevention and Treatment of Affective Disorders. London, England: Academic Press; 1979:289-299
4. Murphy JM, Monson RR, Olivier DC, et al. Affective disorders and mortality: a general population study. Arch Gen Psychiatry 1987;44:473-480
5. Rabins PV, Harvis K, Koven S. High fatality rates of late-life depression associated with cardiovascular disease. J Affect Disord 1985;9:165-167
6. Weeke A, Vaeth M. Excess mortality of bipolar and unipolar manic-depressive patients. J Affect Disord 1986;11:227-234
7. Avery D, Winokur G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 1976;33: 1029-1037
8. Glassman AH, Helzer JE, Covey LS. Smoking, smoking cessation, and major depression. JAMA 1990;264:1546-1549
9. Aromaa A, Raitasalo R, Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand 1994;89(suppl 377):77-82
10. Everson SA, Goldberg DE, Kaplan GA. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996;58:113-121
11. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93: 1976-1980
12. Pratt LA, Ford DE, Crum RM, et al. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 1996;94:3123-3129
13. Vogt T, Pope C, Mullooly J, et al. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health 1994;84:227-231
14. Ford DE, Mead LA, Chang PP, et al. Depression predicts cardiovascular disease in men: the precursors study [abstract]. Circulation 1994;90:I-614
15. Schleifer SJ, Macari-Hinson MM, Coyle DA. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149: 1785-1789
16. Carney RM, Rich MW, Freedland KE. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-633
17. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005
18. Glassman AH, Bigger JT Jr, Giardina EGV, et al. Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet 1979;1:468-472
19. Muller OF, Goodman N, Bellet S. The hypotensive effect of imipramine hydrochloride in patients with cardiovascular disease. Clin Pharmacol Ther 1961;2:300-307
20. Hayes JR, Born GF, Rosenbaum AH. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants. Mayo Clin Proc 1977;52:509-512
21. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363-369
22. Giardina EGV, Bigger JT Jr, Glassman AH. Desmethylimipramine and imipramine on left ventricular function and the ECG: a randomized crossover design. Int J Cardiol 1983;2:375-385
23. Kopera H. Anticholinergic and blood pressure effects of mianserine. amitriptyline and placebo. Br J Clin Pharmacol 1978;5(1, suppl):29S-34S
24. Roose SP, Dalack GW, Glassman AH, et al. Is doxepin a safer tricyclic for the heart? J Clin Psychiatry 1991;52:338-341
25. Roose SP, Glassman AH, Siris SG, et al. Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmacol 1981;1:316-319
26. Thayssen P, Bjerre M, Kragh-Sorensen P. Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharmacology (Berl) 1981;74:360-364
27. Vohra J, Burrows GD, Hunt D, et al. The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol 1975;3:219-227
28. Weld FM, Bigger JT Jr. Electrophysiological effects on ovine cardiac Purkinje and ventricular muscle fibers. Circ Res 1980;46:167-175
29. Rawling DA, Fozzard HA. Effects of imipramine on cellular electrophysiologic properties of cardiac Purkinje fibers. J Pharmacol Exp Ther 1979; 209:371-375
30. Roose SP, Glassman AH, Giardina EGV, et al. Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 1987;44:273-275
31. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412
32. Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233
33. Greenberg HM, Dwyer EM Jr, Hochman JS, et al. Interaction of ischemia and ecainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J 1995;74:631-635
34. Roose SP, Dalack GW, Glassman AH, et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991; 148:512-516
35. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-291
36. Roose SP, Glassman AH, Attia E, et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998;155: 660-665
37. Shapiro PA, Lesperance F, Frasure-Smith N, et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (The "SADHAT" Trial). Am Heart J 1999;137:1100-1106